Whilst multiple trials show that THC and CBD enhance MS indications, the impact is modest. There is certainly also no convincing proof that cannabinoids can slow or reverse the sickness’s progression.An additional 2022 trial involving 186 Older people with pain, insomnia, anxiousness or depressive symptoms located no change in stress and anxiety